Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Capital Leases for 3 consecutive years, with $47000.0 as the latest value for Q3 2025.

  • Quarterly Capital Leases fell 45.98% to $47000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $47000.0 through Sep 2025, down 45.98% year-over-year, with the annual reading at $70000.0 for FY2024, 52.7% down from the prior year.
  • Capital Leases hit $47000.0 in Q3 2025 for Camp4 Therapeutics, down from $59000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $148000.0 in Q4 2023 to a low of $47000.0 in Q3 2025.
  • Historically, Capital Leases has averaged $78166.7 across 3 years, with a median of $64500.0 in 2024.
  • Biggest five-year swings in Capital Leases: tumbled 52.7% in 2024 and later plummeted 45.98% in 2025.
  • Year by year, Capital Leases stood at $148000.0 in 2023, then crashed by 52.7% to $70000.0 in 2024, then plummeted by 32.86% to $47000.0 in 2025.
  • Business Quant data shows Capital Leases for CAMP at $47000.0 in Q3 2025, $59000.0 in Q2 2025, and $58000.0 in Q1 2025.